Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Connexin 43 confers chemoresistance through activating PI3K
Kevin J. Pridham, Farah Shah, Kasen R. Hutchings, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 75
Integrins in cancer: Emerging mechanisms and therapeutic opportunities
Fangfang Liu, Qiong Wu, Zigang Dong, et al.
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108458-108458
Open Access | Times Cited: 72
MicroRNA-206 in human cancer: Mechanistic and clinical perspectives
Leila Bahari Khasraghi, Morteza Nouri, Masoud Vazirzadeh, et al.
Cellular Signalling (2022) Vol. 101, pp. 110525-110525
Closed Access | Times Cited: 39
Systematic Review of Photodynamic Therapy in Gliomas
Tiffaney Hsia, Julia L. Small, Anudeep Yekula, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3918-3918
Open Access | Times Cited: 32
GJA1-20k, a Short Isoform of Connexin43, from Its Discovery to Its Potential Implication in Cancer Progression
Sarah Fournier, Jonathan Clarhaut, Laurent Cronier, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 180-180
Open Access
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach
M. Campelo, Laís Reis-das-Mercês, Amanda Vidal, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mapping the Anti-Cancer Activity of α-Connexin Carboxyl-Terminal (aCT1) Peptide in Resistant HER2+ Breast Cancer
Kimberly M. Baker, Melissa Abt, Emma H. Doud, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 423-423
Open Access | Times Cited: 3
Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta
Kevin J. Pridham, Kasen Reed Hutchings, Patrick J. Beck, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109921-109921
Open Access | Times Cited: 3
αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform
Jingru Che, Thomas J. DePalma, Hemamylammal Sivakumar, et al.
Biotechnology and Bioengineering (2022) Vol. 120, Iss. 4, pp. 1108-1119
Open Access | Times Cited: 13
Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis
Erin E. Mulkearns-Hubert, Nicole Hajdari, Ellen S. Hong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression
Junlin Liang, Jiaxiu Xie, Junhui He, et al.
Cancer Reports (2024) Vol. 7, Iss. 10
Open Access | Times Cited: 2
Connexins and Glucose Metabolism in Cancer
Jennifer Jones, Thomas M. Bodenstine
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10172-10172
Open Access | Times Cited: 10
Systematic review of photodynamic therapy in gliomas
Tiffaney Hsia, Julia L. Small, Anudeep Yekula, et al.
(2023)
Open Access | Times Cited: 6
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
Li Sui, Xiaofang Xie, Peng Fu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 8
Increased interaction between connexin43 and microtubules is critical for glioblastoma stem-like cell maintenance and tumorigenicity.
James W. Smyth, Sujuan Guo, L O'Rourke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Multiple approaches for the evaluation of connexin-43 expression and function in macrophages
Júlia Costa de Sousa, Stephanie Alexia Cristina Silva Santos, Eleonora Kurtenbach
Journal of Immunological Methods (2024) Vol. 533, pp. 113741-113741
Closed Access | Times Cited: 1
Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide
Yangjie Song, Qi Huang, Qing Pu, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 9, pp. 1380-1390
Closed Access | Times Cited: 1
Tonabersat enhances temozolomide‐mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition
Elena N. C. Schmidt, Bernd O. Evert, Benedikt Pregler, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 1
Connexin 43 peptidic medicine for glioblastoma stem cells
Zhi Sheng
EBioMedicine (2021) Vol. 64, pp. 103205-103205
Open Access | Times Cited: 4
Connexin 45 is a novel suppressor of melanoma metastasis
Mikako Saito, Naruwa Tokunaga, Takashi Saito, et al.
Cytotechnology (2022) Vol. 75, Iss. 2, pp. 103-113
Open Access | Times Cited: 3
Connexin-43 in Cancer: Above and Beyond Gap Junctions!
Shishir Paunikar, Luca Tamagnone
Cancers (2024) Vol. 16, Iss. 24, pp. 4191-4191
Open Access
Molecular Basis of Oncogenic PI3K Proteins
Zhi Sheng, Patrick J. Beck, Maegan Gabby, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 77-77
Open Access
Cell-cell junctional proteins in cancer
Aparajita Das, Sarbani Giri, Pubali Dey
Advances in clinical chemistry (2024), pp. 93-142
Closed Access
CRISPR-Induced Loss of Connexin 43 Expression Sensitizes KRAS Mutant Cells to Cisplatin.
Stephen F. Martin, David Mu
PubMed (2022) Vol. 2022
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top